These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38124549)

  • 1. Balancing between competition and regulation in healthcare markets.
    Trottmann M; Stam P; Visser J; Brammli-Greenberg S
    Health Econ Policy Law; 2023 Dec; ():1-10. PubMed ID: 38124549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed competition in the United States: How well is it promoting equity and efficiency?
    Ellis RP; Hoagland A; Acquatella A
    Health Econ Policy Law; 2024 Jan; ():1-15. PubMed ID: 38186232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does managed competition affect hospital prices in a social health insurance system? The Colombian case.
    Fernando R; Leticia AB; Antonio J T
    Health Policy Plan; 2018 Nov; 33(9):1037-1046. PubMed ID: 30462221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The private rental housing market before and during the COVID-19 pandemic: A submarket analysis in Cracow, Poland.
    Tomal M; Helbich M
    Environ Plan B Urban Anal City Sci; 2022 Jul; 49(6):1646-1662. PubMed ID: 35791345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing the managed care market competition.
    Olden PC
    Med Group Manage J; 1996; 43(3):14-6, 19-22. PubMed ID: 10157087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dropped out or pushed out? Insurance market exit and provider market power in Medicare Advantage.
    Pelech D
    J Health Econ; 2017 Jan; 51():98-112. PubMed ID: 28126701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The marketplace in health care reform. The demographic limitations of managed competition.
    Kronick R; Goodman DC; Wennberg J; Wagner E
    N Engl J Med; 1993 Jan; 328(2):148-52. PubMed ID: 8416437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public healthcare interests require strict competition enforcement.
    Loozen EM
    Health Policy; 2015 Jul; 119(7):882-8. PubMed ID: 25739723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring limits to market-based reform: managed competition and rehabilitation home care services in Ontario.
    Randall GE; Williams AP
    Soc Sci Med; 2006 Apr; 62(7):1594-604. PubMed ID: 16198035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relations between business model efficiency and novelty, and outcome while accounting for managed competition contract: a quantitative study among Dutch physiotherapy primary healthcare organisations.
    IJntema R; Barten DJ; Duits H; Tjemkes B; Veenhof C
    BMC Health Serv Res; 2022 Aug; 22(1):990. PubMed ID: 35922844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roadmaps to managed competition: to what extent does South Africa meet the preconditions for equity and efficiency?
    van den Heever A
    Health Econ Policy Law; 2024 Jan; ():1-18. PubMed ID: 38173263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition in California's Medi-Cal Managed Care Market Assessed by Herfindahl-Hirschman Index.
    Tawil M; DiGiorgio AM
    Inquiry; 2022; 59():469580221127063. PubMed ID: 36168304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition in hospital and health insurance markets: a review and research agenda.
    Morrisey MA
    Health Serv Res; 2001 Apr; 36(1 Pt 2):191-221. PubMed ID: 11327174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging issues in the antitrust definition of healthcare markets.
    Dranove D; White WD
    Health Econ; 1998 Mar; 7(2):167-70. PubMed ID: 9565173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do health insurer market concentration and bargaining power with hospitals affect health insurance premiums?
    Trish EE; Herring BJ
    J Health Econ; 2015 Jul; 42():104-14. PubMed ID: 25910690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.